Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ZNF383 ZNF630 ZNF22 ZNF695 ZNF280D ZNF732 ZNF678 ZNF43 ZNF558 ZNF286B ZNF195 ZNF721 ZNF84 ZNF606 ZNF679 PRDM15 ZNF730 ZNF518A	4.58e-07	1412	66	18	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ZNF383 ZNF630 ZNF22 ZNF695 ZNF280D ZNF732 ZNF678 ZNF43 ZNF558 ZNF286B ZNF195 ZNF721 ZNF84 ZNF606 ZNF679 PRDM15 ZNF730 ZNF518A	7.40e-07	1459	66	18	GO:0000977
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	ZNF383 ZNF630 ZNF22 ZNF695 ZNF280D ZNF732 ZNF678 ZNF43 ZNF286B ZNF195 ZNF721 ZNF84 ZNF606 ZNF679 PRDM15 ZNF730	2.07e-06	1244	66	16	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	ZNF383 ZNF630 ZNF22 ZNF695 ZNF280D ZNF732 ZNF678 ZNF43 ZNF286B ZNF195 ZNF721 ZNF84 ZNF606 ZNF679 PRDM15 ZNF730	2.73e-06	1271	66	16	GO:0000987
GeneOntologyMolecularFunction	1-phosphatidylinositol-3-kinase activity	PIK3C2G PIK3R1	5.81e-04	11	66	2	GO:0016303
GeneOntologyCellularComponent	endolysosome	SLC15A4 PRKCD TLR7	1.10e-04	30	65	3	GO:0036019
Domain	zf-C2H2	ZNF462 ZNF383 ZNF630 ZNF22 ZNF695 ZNF280D ZNF732 ZNF678 ZNF43 ZNF558 ZNF286B ZNF195 ZNF721 ZNF84 ZNF606 ZNF679 PRDM15 ZNF730 ZNF518A	6.85e-13	693	63	19	PF00096
Domain	ZINC_FINGER_C2H2_2	ZNF462 ZNF383 ZNF630 ZNF22 ZNF695 ZNF280D ZNF732 ZNF678 ZNF43 ZNF558 ZNF286B ZNF195 ZNF721 ZNF84 ZNF606 ZNF679 PRDM15 ZNF730 ZNF518A	4.87e-12	775	63	19	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF462 ZNF383 ZNF630 ZNF22 ZNF695 ZNF280D ZNF732 ZNF678 ZNF43 ZNF558 ZNF286B ZNF195 ZNF721 ZNF84 ZNF606 ZNF679 PRDM15 ZNF730 ZNF518A	5.09e-12	777	63	19	PS00028
Domain	Znf_C2H2	ZNF462 ZNF383 ZNF630 ZNF22 ZNF695 ZNF280D ZNF732 ZNF678 ZNF43 ZNF558 ZNF286B ZNF195 ZNF721 ZNF84 ZNF606 ZNF679 PRDM15 ZNF730 ZNF518A	9.43e-12	805	63	19	IPR007087
Domain	ZnF_C2H2	ZNF462 ZNF383 ZNF630 ZNF22 ZNF695 ZNF280D ZNF732 ZNF678 ZNF43 ZNF558 ZNF286B ZNF195 ZNF721 ZNF84 ZNF606 ZNF679 PRDM15 ZNF730 ZNF518A	1.01e-11	808	63	19	SM00355
Domain	Znf_C2H2-like	ZNF462 ZNF383 ZNF630 ZNF22 ZNF695 ZNF280D ZNF732 ZNF43 ZNF558 ZNF286B ZNF195 ZNF721 ZNF84 ZNF606 ZNF679 PRDM15 ZNF730 ZNF518A	7.57e-11	796	63	18	IPR015880
Domain	Znf_C2H2/integrase_DNA-bd	ZNF462 ZNF383 ZNF630 ZNF22 ZNF695 ZNF732 ZNF43 ZNF558 ZNF286B ZNF195 ZNF721 ZNF84 ZNF606 ZNF679 PRDM15 ZNF730 ZNF518A	8.29e-11	694	63	17	IPR013087
Domain	-	ZNF462 ZNF383 ZNF630 ZNF22 ZNF695 ZNF732 ZNF43 ZNF558 ZNF286B ZNF195 ZNF721 ZNF84 ZNF606 ZNF679 PRDM15 ZNF730	5.83e-10	679	63	16	3.30.160.60
Domain	KRAB	ZNF383 ZNF630 ZNF695 ZNF732 ZNF43 ZNF558 ZNF195 ZNF84 ZNF606 ZNF679 ZNF730	2.78e-08	358	63	11	PS50805
Domain	KRAB	ZNF383 ZNF630 ZNF695 ZNF732 ZNF43 ZNF558 ZNF195 ZNF84 ZNF606 ZNF679 ZNF730	2.78e-08	358	63	11	PF01352
Domain	KRAB	ZNF383 ZNF630 ZNF695 ZNF732 ZNF43 ZNF558 ZNF195 ZNF84 ZNF606 ZNF679 ZNF730	3.79e-08	369	63	11	SM00349
Domain	KRAB	ZNF383 ZNF630 ZNF695 ZNF732 ZNF43 ZNF558 ZNF195 ZNF84 ZNF606 ZNF679 ZNF730	3.90e-08	370	63	11	IPR001909
Domain	zf-C2H2_6	ZNF695 ZNF732 ZNF43 ZNF558 ZNF195 ZNF721 ZNF84 ZNF606 ZNF730	1.02e-06	314	63	9	PF13912
Domain	VWF_A	MDN1 CACHD1 ITGA2 GABPB1	3.48e-04	99	63	4	IPR002035
Domain	LRR_5	LHCGR TLR7	4.95e-04	10	63	2	PF13306
Domain	LRR_5	LHCGR TLR7	4.95e-04	10	63	2	IPR026906
Domain	zf-H2C2_2	ZNF383 ZNF286B	9.93e-04	14	63	2	PF13465
Domain	VWFA	MDN1 CACHD1 ITGA2	2.68e-03	82	63	3	PS50234
Domain	VWA	MDN1 CACHD1 ITGA2	2.87e-03	84	63	3	SM00327
Domain	LRRNT	LHCGR TLR7 AMIGO1	4.43e-03	98	63	3	IPR000372
Domain	LRRNT	LHCGR TLR7 AMIGO1	4.43e-03	98	63	3	SM00013
Domain	L_dom-like	LHCGR EGFR XRRA1 TLR7 AMIGO1	4.96e-03	328	63	5	IPR032675
Pathway	WP_GLIOBLASTOMA_SIGNALING	BRCA2 EGFR PIK3C2G PIK3R1 PRKCD	6.36e-06	83	45	5	M39637
Pubmed	Regulator of sex-limitation (Rsl) encodes a pair of KRAB zinc-finger genes that control sexually dimorphic liver gene expression.	ZNF695 ZNF43 ZNF195 ZNF721 ZNF679	2.42e-09	29	66	5	14563677
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF383 ZNF22 ZNF678 ZNF558 ZNF195 ZNF721 ZNF84	5.53e-08	181	66	7	37372979
Pubmed	EGF-stimulated signaling by means of PI3K, PLCgamma1, and PKC isozymes regulates branching morphogenesis of the fetal mouse submandibular gland.	EGFR PIK3R1 PRKCD	1.84e-06	13	66	3	12761849
Pubmed	HIV Nef enhances Tat-mediated viral transcription through a hnRNP-K-nucleated signaling complex.	PIK3C2G PIK3R1 PRKCD	2.92e-06	15	66	3	18854243
Pubmed	Aberrant expression of epidermal growth factor receptor and its interaction with protein kinase C δ in inflammation associated neoplastic transformation of human esophageal epithelium in high risk populations.	EGFR PRKCD	3.55e-06	2	66	2	21155880
Pubmed	A genetic library screen for signaling proteins that interact with phosphorylated T cell costimulatory receptors.	ICOS PIK3R1	3.55e-06	2	66	2	17014982
Pubmed	High mannose-binding Pseudomonas fluorescens lectin (PFL) downregulates cell surface integrin/EGFR and induces autophagy in gastric cancer cells.	EGFR ITGA2	3.55e-06	2	66	2	26850110
Pubmed	EGF-Receptor-Dependent TLR7 Signaling in Macrophages Promotes Glomerular Injury in Crescentic Glomerulonephritis.	EGFR TLR7	3.55e-06	2	66	2	37268107
Pubmed	VPS35 promotes cell proliferation via EGFR recycling and enhances EGFR inhibitors response in gastric cancer.	EGFR VPS35	3.55e-06	2	66	2	36738481
Pubmed	Extracellular HIV-1 Tat protein induces a rapid and selective activation of protein kinase C (PKC)-alpha, and -epsilon and -zeta isoforms in PC12 cells.	PIK3C2G PIK3R1 PRKCD	8.47e-06	21	66	3	9446795
Pubmed	HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes.	PIK3C2G PIK3R1 PRKCD	9.80e-06	22	66	3	11154208
Pubmed	Transactivation of the epidermal growth factor receptor is involved in the lutropin receptor-mediated down-regulation of ovarian aromatase expression in vivo.	LHCGR EGFR	1.06e-05	3	66	2	20093417
Pubmed	EGF receptor and PKCδ kinase activate DNA damage-induced pro-survival and pro-apoptotic signaling via biphasic activation of ERK and MSK1 kinases.	EGFR PRKCD	1.06e-05	3	66	2	30679314
Pubmed	p85α promotes nucleolin transcription and subsequently enhances EGFR mRNA stability and EGF-induced malignant cellular transformation.	EGFR PIK3R1	1.06e-05	3	66	2	26918608
Pubmed	Lung cancer cells that survive ionizing radiation show increased integrin α2β1- and EGFR-dependent invasiveness.	EGFR ITGA2	1.06e-05	3	66	2	23951036
Pubmed	Platelet-derived growth factor mimics phorbol diester action on epidermal growth factor receptor phosphorylation at threonine-654.	EGFR PRKCD	1.06e-05	3	66	2	2987962
Pubmed	Phorbol 12-myristate 13-acetate induces epidermal growth factor receptor transactivation via protein kinase Cdelta/c-Src pathways in glioblastoma cells.	EGFR PRKCD	1.06e-05	3	66	2	15618223
Pubmed	Phosphorylation of PKCδ by FER tips the balance from EGFR degradation to recycling.	EGFR PRKCD	1.06e-05	3	66	2	33411917
Pubmed	PKCδ localization at the membrane increases matrix traction force dependent on PLCγ1/EGFR signaling.	EGFR PRKCD	1.06e-05	3	66	2	24155954
Pubmed	A chimeric cyclic interferon-α2b peptide induces apoptosis by sequential activation of phosphatidylinositol 3-kinase, protein kinase Cδ and p38 MAP kinase.	PIK3R1 PRKCD	1.06e-05	3	66	2	23562842
Pubmed	ICOS ligation recruits the p50alpha PI3K regulatory subunit to the immunological synapse.	ICOS PIK3R1	1.06e-05	3	66	2	18641334
Pubmed	Tumor-promoting phorbol diesters cause the phosphorylation of epidermal growth factor receptors in normal human fibroblasts at threonine-654.	EGFR PRKCD	1.06e-05	3	66	2	2984676
Pubmed	BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations.	BRCA2 EGFR	1.06e-05	3	66	2	28591715
Pubmed	Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120.	PIK3C2G PIK3R1 PRKCD	1.46e-05	25	66	3	15689238
Pubmed	Human POGZ modulates dissociation of HP1alpha from mitotic chromosome arms through Aurora B activation.	ZNF462 ZNF280D ZNF195 ZNF518A	1.94e-05	83	66	4	20562864
Pubmed	Transforming growth factor-β-induced protein (TGFBI) suppresses mesothelioma progression through the Akt/mTOR pathway.	EGFR PIK3R1	2.12e-05	4	66	2	21701776
Pubmed	The kinase domain and membrane localization determine intracellular interactions between epidermal growth factor receptors.	EGFR PIK3R1	2.12e-05	4	66	2	7531698
Pubmed	SH2 domains of the p85 alpha subunit of phosphatidylinositol 3-kinase regulate binding to growth factor receptors.	EGFR PIK3R1	2.12e-05	4	66	2	1372092
Pubmed	Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and P85 alpha.	EGFR PIK3R1	2.12e-05	4	66	2	7797556
Pubmed	Insulin receptor substrate is a mediator of phosphoinositide 3-kinase activation in quiescent pancreatic cancer cells.	EGFR PIK3R1	2.12e-05	4	66	2	16230374
Pubmed	Integrin-EGFR interaction regulates anoikis resistance in colon cancer cells.	EGFR ITGA2	2.12e-05	4	66	2	31641961
Pubmed	Increased proliferation and altered growth factor dependence of human mammary epithelial cells overexpressing the Gab2 docking protein.	EGFR PIK3R1	3.53e-05	5	66	2	16253990
Pubmed	Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor.	EGFR PIK3R1	3.53e-05	5	66	2	9356464
Pubmed	Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway.	EGFR PIK3R1	3.53e-05	5	66	2	23968914
Pubmed	Dominance of ErbB-1 heterodimers in lung epithelial cells overexpressing ErbB-2. Both ErbB-1 and ErbB-2 contribute significantly to tumorigenicity.	EGFR PIK3R1	3.53e-05	5	66	2	10572067
Pubmed	Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.	EGFR PIK3R1	3.53e-05	5	66	2	9886492
Pubmed	The signaling network of transforming growth factor beta1, protein kinase Cdelta, and integrin underlies the spreading and invasiveness of gastric carcinoma cells.	PRKCD ITGA2	3.53e-05	5	66	2	16055706
Pubmed	EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation.	EGFR PIK3R1	3.53e-05	5	66	2	29677490
Pubmed	PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer.	EGFR PIK3R1	3.53e-05	5	66	2	21278786
Pubmed	Hck enhances the adherence of lipopolysaccharide-stimulated macrophages via Cbl and phosphatidylinositol 3-kinase.	EGFR PIK3R1	3.53e-05	5	66	2	10799548
Pubmed	A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS).	ICOS PIK3R1	3.53e-05	5	66	2	12538664
Pubmed	FAK integrates growth-factor and integrin signals to promote cell migration.	EGFR PIK3R1	3.53e-05	5	66	2	10806474
Pubmed	Regulation of lysophosphatidic acid-induced epidermal growth factor receptor transactivation and interleukin-8 secretion in human bronchial epithelial cells by protein kinase Cdelta, Lyn kinase, and matrix metalloproteinases.	EGFR PRKCD	3.53e-05	5	66	2	16687414
Pubmed	HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors.	EGFR PIK3R1	3.53e-05	5	66	2	16843263
Pubmed	Basement membrane localization of Frem3 is independent of the Fras1/Frem1/Frem2 protein complex within the sublamina densa.	NID1 FREM3	3.53e-05	5	66	2	17596926
Pubmed	The ectodomain of cadherin-11 binds to erbB2 and stimulates Akt phosphorylation to promote cranial neural crest cell migration.	EGFR PIK3R1	5.29e-05	6	66	2	29190819
Pubmed	ERK negatively regulates the epidermal growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase.	EGFR PIK3R1	5.29e-05	6	66	2	11896055
Pubmed	NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma.	EGFR PIK3R1	5.29e-05	6	66	2	22439932
Pubmed	Mechanisms of kringle fragment of urokinase-induced vascular smooth muscle cell migration.	EGFR PIK3R1	5.29e-05	6	66	2	17574041
Pubmed	cbl-b inhibits epidermal growth factor receptor signaling.	EGFR PIK3R1	5.29e-05	6	66	2	10086340
Pubmed	ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling.	EGFR PIK3R1	5.29e-05	6	66	2	9130710
Pubmed	A TRAF-like motif of the inducible costimulator ICOS controls development of germinal center TFH cells via the kinase TBK1.	ICOS PIK3R1	5.29e-05	6	66	2	27135603
Pubmed	Galpha(i1) and Galpha(i3) are required for epidermal growth factor-mediated activation of the Akt-mTORC1 pathway.	EGFR PIK3R1	5.29e-05	6	66	2	19401591
Pubmed	A novel positive feedback loop mediated by the docking protein Gab1 and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling.	EGFR PIK3R1	5.29e-05	6	66	2	10648629
Pubmed	SNX12 role in endosome membrane transport.	EGFR VPS35	5.29e-05	6	66	2	22719997
Pubmed	Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase.	EGFR PIK3R1	5.29e-05	6	66	2	9890970
Pubmed	Inhibition of Src family kinases blocks epidermal growth factor (EGF)-induced activation of Akt, phosphorylation of c-Cbl, and ubiquitination of the EGF receptor.	EGFR PIK3R1	7.40e-05	7	66	2	11994282
Pubmed	Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis.	EGFR PIK3R1	7.40e-05	7	66	2	11896612
Pubmed	A p85α-osteopontin axis couples the receptor ICOS to sustained Bcl-6 expression by follicular helper and regulatory T cells.	ICOS PIK3R1	7.40e-05	7	66	2	25436971
Pubmed	Protein kinase C-delta and phosphatidylinositol 3-kinase/Akt activate mammalian target of rapamycin to modulate NF-kappaB activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cells.	PIK3R1 PRKCD	7.40e-05	7	66	2	19074768
Pubmed	Characterization of PXK as a protein involved in epidermal growth factor receptor trafficking.	EGFR PIK3R1	7.40e-05	7	66	2	20086096
Pubmed	Identification of a new adapter protein that may link the common beta subunit of the receptor for granulocyte/macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 to phosphatidylinositol 3-kinase.	EGFR PIK3R1	9.86e-05	8	66	2	7499252
Pubmed	Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR.	ZNF695 ZNF43 ZNF721	1.13e-04	49	66	3	9630514
Pubmed	TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin.	EGFR PIK3R1	1.27e-04	9	66	2	15107835
Pubmed	Predisposition for TMPRSS2-ERG fusion in prostate cancer by variants in DNA repair genes.	BRCA2 ESCO1	1.27e-04	9	66	2	19861517
Pubmed	Structural basis for activation of trimeric Gi proteins by multiple growth factor receptors via GIV/Girdin.	EGFR PIK3R1	1.27e-04	9	66	2	25187647
Pubmed	Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation.	EGFR PIK3R1	1.27e-04	9	66	2	11094073
Pubmed	Activation of protein kinase C delta by IFN-gamma.	EGFR PRKCD	1.27e-04	9	66	2	12817007
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZNF462 PER3 ZNF280D ZNF43 ZNF286B ZNF195 ZNF721 ZNF679	1.43e-04	808	66	8	20412781
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CLK1 PIK3R1 CEP57L1 ZNF558 ARFGEF2 ZNF84 CACHD1 ZNF606 SEC31B GEN1	1.47e-04	1285	66	10	35914814
Pubmed	Differential signaling by the epidermal growth factor-like growth factors neuregulin-1 and neuregulin-2.	EGFR PIK3R1	1.58e-04	10	66	2	9756944
Pubmed	Gab1 is an integrator of cell death versus cell survival signals in oxidative stress.	EGFR PIK3R1	1.58e-04	10	66	2	12808090
Pubmed	Extracellular human immunodeficiency virus type-1 Tat protein activates phosphatidylinositol 3-kinase in PC12 neuronal cells.	PIK3C2G PIK3R1	1.58e-04	10	66	2	8798481
Pubmed	Expression of HIV-1 nef decreases basal phosphatidyl-inositol 3-kinase activity.	PIK3C2G PIK3R1	1.58e-04	10	66	2	9247029
Pubmed	Functional analysis of the SRY-KRAB interaction in mouse sex determination.	ZNF43 ZNF721	1.58e-04	10	66	2	18588511
Pubmed	The HIV-1 nef protein interferes with phosphatidylinositol 3-kinase activation 1.	PIK3C2G PIK3R1	1.58e-04	10	66	2	8636073
Pubmed	A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma.	EGFR PRKCD	1.58e-04	10	66	2	7690989
Pubmed	Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins.	EGFR PIK3R1	1.58e-04	10	66	2	8662998
Pubmed	Sry associates with the heterochromatin protein 1 complex by interacting with a KRAB domain protein.	ZNF43 ZNF721	1.93e-04	11	66	2	15469996
Pubmed	Protein kinase Cdelta regulates apoptosis via activation of STAT1.	EGFR PRKCD	1.93e-04	11	66	2	15322115
Pubmed	HIV-1 gp120-induced TNF-{alpha} production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways.	PIK3C2G PIK3R1	1.93e-04	11	66	2	16081599
Pubmed	Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells.	PIK3C2G PIK3R1	1.93e-04	11	66	2	12584329
Pubmed	Ligands of CD4 inhibit the association of phospholipase Cgamma1 with phosphoinositide 3 kinase in T cells: regulation of this association by the phosphoinositide 3 kinase activity.	PIK3C2G PIK3R1	1.93e-04	11	66	2	9808187
Pubmed	Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation.	EGFR PRKCD	1.93e-04	11	66	2	7543024
Pubmed	HIV-1 Tat induces tyrosine phosphorylation of p125FAK and its association with phosphoinositide 3-kinase in PC12 cells.	PIK3C2G PIK3R1	1.93e-04	11	66	2	9708406
Pubmed	HIV-Nef enhances interleukin-2 production and phosphatidylinositol 3-kinase activity in a human T cell line.	PIK3C2G PIK3R1	1.93e-04	11	66	2	10985305
Pubmed	Fluctuations in AKT and PTEN Activity Are Linked by the E3 Ubiquitin Ligase cCBL.	EGFR PIK3R1	1.93e-04	11	66	2	34831026
Pubmed	Human immunodeficiency virus type 1 tat-mediated cytotoxicity of human brain microvascular endothelial cells.	PIK3C2G PIK3R1	2.31e-04	12	66	2	14602571
Pubmed	Colony-stimulating factor-1 requires PI3-kinase-mediated metabolism for proliferation and survival in myeloid cells.	PIK3C2G PIK3R1	2.31e-04	12	66	2	16514418
Pubmed	HIV-1 Nef plays an essential role in two independent processes in CD4 down-regulation: dissociation of the CD4-p56(lck) complex and targeting of CD4 to lysosomes.	PIK3C2G PIK3R1	2.31e-04	12	66	2	10208934
Pubmed	Recruitment of phosphatidylinositol 3-kinase to CD28 inhibits HIV transcription by a Tat-dependent mechanism.	PIK3C2G PIK3R1	2.31e-04	12	66	2	12077252
Pubmed	Down-regulation of LFA-1-mediated T cell adhesion induced by the HIV envelope glycoprotein gp160 requires phosphatidylinositol-3-kinase activity.	PIK3C2G PIK3R1	2.31e-04	12	66	2	9341793
Pubmed	Phosphatidylinositol 3-kinase regulates human immunodeficiency virus type 1 replication following viral entry in primary CD4+ T lymphocytes and macrophages.	PIK3C2G PIK3R1	2.31e-04	12	66	2	12551992
Pubmed	Protein kinase C-alpha and protein kinase C-epsilon are required for Grb2-associated binder-1 tyrosine phosphorylation in response to platelet-derived growth factor.	EGFR PIK3R1	2.31e-04	12	66	2	11940581
Pubmed	Ser727/Tyr701-phosphorylated Stat1 is required for the regulation of c-Myc, cyclins, and p27Kip1 associated with ATRA-induced G0/G1 arrest of U-937 cells.	EGFR PRKCD	2.31e-04	12	66	2	12637327
Pubmed	Genetic mutations associated with cigarette smoking in pancreatic cancer.	BRCA2 EGFR PIK3R1	2.39e-04	63	66	3	19351817
Pubmed	Epigenetic gene silencing by the SRY protein is mediated by a KRAB-O protein that recruits the KAP1 co-repressor machinery.	ZNF43 ZNF721	2.73e-04	13	66	2	19850934
Pubmed	Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid Jurkat cells.	PIK3C2G PIK3R1	2.73e-04	13	66	2	9394803
Pubmed	HIV-1 Nef in macrophage-mediated disease pathogenesis.	PIK3C2G PIK3R1	2.73e-04	13	66	2	23215766
Pubmed	Matrix metalloproteinase-14 mediates formation of bile ducts and hepatic maturation of fetal hepatic progenitor cells.	EGFR NID1	3.18e-04	14	66	2	26724533
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF462 ZNF383 ZNF630 ZNF22 ZNF695 ZNF732 ZNF678 ZNF43 ZNF558 ZNF286B ZNF195 ZNF721 ZNF84 ZNF606 ZNF679 PRDM15 ZNF730 ZNF518A	2.68e-13	718	50	18	28
Coexpression	ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_POSITIVE	ZNF280D PIK3R1 ZNF721 ESCO1 ZNF518A	2.30e-06	84	66	5	M40895
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TNIK FILIP1 ATP8A1 EGFR CACHD1	7.70e-06	183	66	5	6847c1252d6bb105524f812658112517fd351eab
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 PIK3C2G ZNF43 GEN1 ZNF730	8.55e-06	187	66	5	057569c9437219ecc396aa6e673b1178a2273837
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK MDN1 ICOS ATP8A1 ZNF280D	9.01e-06	189	66	5	d05e043d0874b8563b9f5514f6c884b35c603e3a
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FILIP1 ATP8A1 EGFR CACHD1 TMEM87A	1.16e-05	199	66	5	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	LPS-IL1RA-Lymphocytic_NKT-T_cells-Erythroid\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TNIK TTF2 ICOS AMIGO1	3.93e-05	128	66	4	c2045f052cc713e52312eb015825711576fcb6c5
ToppCell	E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor\|E16.5-samps / Age Group, Lineage, Cell class and subclass	ATP8A1 PER3 TMEM116 PIK3C2G	8.27e-05	155	66	4	9cad73d0b8ead289e1073d1a2e00bbeb1228308c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA2 ZNF732 GEN1 ZNF730	8.48e-05	156	66	4	955547dfeb1b1ad4957b4338701055726b22619f
ToppCell	ICU-SEP-Lymphocyte-T_NK-CD8_TCM\|ICU-SEP / Disease, Lineage and Cell Type	CATSPERB CACHD1 ITGA2 ZNF730	8.69e-05	157	66	4	8ff52e532b149887c18f76b151325281821692b5
ToppCell	mild_COVID-19_(asymptomatic)-CD4+_T_naive\|World / disease group, cell group and cell class (v2)	SERPINC1 CACHD1 FREM3 TRAV23DV6	8.69e-05	157	66	4	23879e65a6acc33d9aad096cd23604a77b0ac9c2
ToppCell	facs-BAT-Fat-3m-Lymphocytic-NK_cell\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNIK ICOS PIK3R1 ITGA2	1.03e-04	164	66	4	cbdb7e893cb3959b9920c0c7c535ace03a5f4986
ToppCell	mild_COVID-19_(asymptomatic)-CD4+_T_naive\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	SERPINC1 CACHD1 FREM3 TRAV23DV6	1.10e-04	167	66	4	78d264af390bd89942ffbb2991dc94f50756d4c9
ToppCell	tumor_Lung-Endothelial_cells-EPCs\|Endothelial_cells / Location, Cell class and cell subclass	TNIK ICOS PIK3R1 TLR7	1.21e-04	171	66	4	dcb6c41980008d0b9eeb54999faff77311554976
ToppCell	droplet-Fat-Mat-18m-Lymphocytic-lymphocyte\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNIK MDN1 ICOS ESCO1	1.24e-04	172	66	4	226de1a5d4a360d3ae01b0235fea19521ec623a0
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FILIP1 ATP8A1 EGFR FREM3	1.26e-04	173	66	4	b799c06a6a5754668e789f70c0c8bc1508568575
ToppCell	3'_v3-blood-Mast-Mast_cells\|blood / Manually curated celltypes from each tissue	ENPP3 CEP57L1 ZNF606 ZNF730	1.35e-04	176	66	4	b9da3deaf62622d47eb30b6be7548253eee95597
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|368C / Donor, Lineage, Cell class and subclass (all cells)	ZNF630 ATP8A1 MTERF2 PIK3R1	1.44e-04	179	66	4	10c7d371937d9d93c12c8d3465430ef9e0c2ec81
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ATP8A1 CATSPERB CACHD1 ITGA2	1.50e-04	181	66	4	576da14ab3107f89e1f44a4a439d1bef5bb42370
ToppCell	Severe-Lymphoid-pDC\|Severe / Condition, Lineage, Cell class and cell subclass	ATP8A1 SLC15A4 TLR7 ZNF730	1.50e-04	181	66	4	2caecb7c5dcdad46fd02b4ffb73cb613ce835187
ToppCell	Severe-Lymphoid-pDC-\|Severe / Condition, Lineage, Cell class and cell subclass	ATP8A1 SLC15A4 TLR7 ZNF730	1.50e-04	181	66	4	277ce4c49121da0990a5933b19d2c6af9bbe253e
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Undetermined\|Fibroblasts / Location, Cell class and cell subclass	TTF2 MTERF2 CEP57L1 GABPB1	1.67e-04	186	66	4	403ac98f72a42721f84fbd7826f251a88ae534a2
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK ICOS PIK3R1 TRAV23DV6	1.67e-04	186	66	4	c793a3d5709ad504c12fc3b2337746d90236d3ca
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ATP8A1 CATSPERB CACHD1 ITGA2	1.67e-04	186	66	4	acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 MDN1 EGFR NID1	1.81e-04	190	66	4	1121eb607a984c59fbffe7220837fc178745aa55
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK ICOS ESCO1 FBXO34	1.81e-04	190	66	4	91ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-B\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FILIP1 ZNF606 MED17 PRDM15	1.81e-04	190	66	4	a8d92645950715d2621bf0064b1b2bb4eb400cb3
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 MDN1 EGFR NID1	1.81e-04	190	66	4	048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	NEPRO BRCA2 GEN1 TMEM87A	1.81e-04	190	66	4	3f0c7d130f66faea778fe567604edf1b4cdf85b3
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	FILIP1 ATP8A1 EGFR CACHD1	1.85e-04	191	66	4	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FILIP1 ATP8A1 EGFR CACHD1	1.85e-04	191	66	4	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	FILIP1 ATP8A1 EGFR CACHD1	1.88e-04	192	66	4	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NEPRO BRCA2 GEN1 TMEM87A	1.88e-04	192	66	4	c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FILIP1 EGFR CACHD1 ITGA2	1.92e-04	193	66	4	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TTF2 BRCA2 ZNF732 ZNF730	1.96e-04	194	66	4	590a9d4f054e6a3685daf752c9354650fcc7d18a
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNIK ICOS ATP8A1 ZNF280D	2.00e-04	195	66	4	4b9663509cc5e3f409f6d0d37640cb301a827d98
ToppCell	mild-B_cell\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZNF286B ARFGEF2 ZNF195 ZNF606	2.00e-04	195	66	4	1e5f1967bcc898318f4e970b844b4a944eb168e5
ToppCell	facs-Lung-nan\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EGFR ENPP3 NID1 CACHD1	2.04e-04	196	66	4	b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCell	facs-Lung-nan-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EGFR ENPP3 NID1 CACHD1	2.04e-04	196	66	4	787c6cd92035e0b1108c2c086c42a229016e476b
ToppCell	Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	TNIK FILIP1 ATP8A1 TMEM87A	2.08e-04	197	66	4	44a59dfb889577b3160a5b13ada1276771a00241
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	EGFR ZNF732 CACHD1 ITGA2	2.08e-04	197	66	4	de772bd2b4cda843777ac879b1087e6444199dfb
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TNIK ENPP3 MED17 SEC31B	2.08e-04	197	66	4	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FILIP1 ATP8A1 EGFR ITGA2	2.08e-04	197	66	4	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	LPS_only-Hematopoietic_Myeloid-Dendritic_cells\|LPS_only / Treatment groups by lineage, cell group, cell type	SLC15A4 PRKCD TLR7 SNX11	2.08e-04	197	66	4	59ddd8ff7dddf3747b988374e1a4d80959db803e
ToppCell	Non-neuronal-Dividing-IPC-IPC-new\|World / Primary Cells by Cluster	BRCA2 EGFR SCAF11 ITGA2	2.12e-04	198	66	4	11d2d4d179bc31ef2897d7ceeaf9bed1b20cbdc0
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TNIK ATP8A1 CACHD1 TMEM87A	2.12e-04	198	66	4	2e2a4e1756bba6f4fbe529559a97d2993c890b4b
ToppCell	Non-neuronal-Dividing-IPC-IPC-new-9\|World / Primary Cells by Cluster	BRCA2 EGFR SCAF11 ITGA2	2.12e-04	198	66	4	c724ef958e14e17a7d8c02b9f842510c0780f635
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FILIP1 ATP8A1 EGFR ITGA2	2.12e-04	198	66	4	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FILIP1 MDN1 EGFR NID1	2.12e-04	198	66	4	a860246bcea847249a78fd2e86ed8e04371060db
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ATP8A1 EGFR CACHD1 TMEM87A	2.16e-04	199	66	4	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ATP8A1 EGFR CACHD1 TMEM87A	2.16e-04	199	66	4	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	PSB-critical-LOC-Epithelial-Basal\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	EGFR PIK3R1 CACHD1 ITGA2	2.16e-04	199	66	4	2add64c3e4cb6384ec381f34c3f1f77e13e3f27c
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	BRCA2 NID1 ZNF721 GABPB1	2.20e-04	200	66	4	d933978b55fefe52cad599b36f6b47a0c7f71f96
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TTF2 BRCA2 ZNF195 GEN1	2.20e-04	200	66	4	4cfe08878a6981bf7b3567f9e82192d8f060ddde
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FILIP1 ATP8A1 EGFR ITGA2	2.20e-04	200	66	4	8683445ad5b70748c4a1f12eb77d47623085147e
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	BRCA2 NID1 ZNF721 GABPB1	2.20e-04	200	66	4	3d932765c31aef1f80a118d51e8e66c50a758dbb
Drug	vinylene	ZNF462 ZNF22 ENPP3 ITGA2 ZNF606 PRDM15 ESCO1	5.65e-06	245	64	7	CID000006326
Drug	halenaquinone	EGFR PIK3C2G PIK3R1	7.54e-06	14	64	3	CID000370346
Disease	intermediate coronary syndrome (is_implicated_in)	SERPINC1 ITGA2	4.33e-05	5	62	2	DOID:8805 (is_implicated_in)
Disease	glucagon measurement	TNIK ICOS PIK3R1 TRAV23DV6	3.15e-04	154	62	4	EFO_0008463
Disease	thrombosis (is_implicated_in)	SERPINC1 ITGA2	4.48e-04	15	62	2	DOID:0060903 (is_implicated_in)
Disease	Common Variable Immunodeficiency	ICOS PRKCD	4.48e-04	15	62	2	C0009447
Disease	gliosarcoma	EGFR SEPTIN14	5.11e-04	16	62	2	C0206726
Disease	Adenocarcinoma of prostate	BRCA2 EGFR	8.05e-04	20	62	2	C0007112
Disease	Glioma	BRCA2 EGFR PIK3R1	8.26e-04	87	62	3	C0017638
Disease	Carcinoma of lung	BRCA2 EGFR	1.07e-03	23	62	2	C0684249
Disease	Glioblastoma Multiforme	EGFR PIK3R1 SEPTIN14	1.67e-03	111	62	3	C1621958
Disease	Neoplasm of uncertain or unknown behavior of ovary	BRCA2 PIK3R1	1.70e-03	29	62	2	C0496920
Disease	Ovarian Carcinoma	BRCA2 PIK3R1	1.82e-03	30	62	2	C0029925
Disease	Breast Cancer, Familial	BRCA2 GEN1	1.82e-03	30	62	2	C0346153

Protein segments in the cluster

Peptide	Gene	Start	Entry
VQEEQKTHTTFKCFS	ZNF280D	311	Q6N043
SKKLHNVFNLSFLNC	AMIGO1	256	Q86WK6
NCTKDQKFSHAVAFS	CATSPERB	921	Q9H7T0
FEDFAHFISKQKSQC	ADAM2	356	Q99965
TKEKIAFFASHQCSN	FBXO34	116	Q9NWN3
DCLQESHSFSKAFNS	ARFGEF2	1616	Q9Y6D5
HPNFVKKNLCNSFSD	CACHD1	881	Q5VU97
KTSDQIHFFFAKLNC	SERPINC1	146	P01008
LTKFCNNHVSTAKYN	ATP8A1	46	Q9Y2Q0
QICKSVNFLHSNKLT	CLK1	271	P49759
QFSKLHSQLQKQFAS	PIK3C2G	1241	O75747
HTGKTEFNFLKCSEQ	PCDHGB4	756	Q9UN71
SKKQNFTFLGHIQTC	MDN1	741	Q9NU22
NFSHSISENFSKQCE	LHCGR	291	P22888
SSKCNINNFIFHKVL	PRKCD	341	Q05655
HTQSKFCKTAFDISI	GABPB1	131	Q06547
KQLCKVSTEHFTQQY	CCNYL2	106	Q5T2Q4
ECKTFTSFHQTLKNN	PER3	501	P56645
LQFHTTFSKKENNQV	NID1	201	P14543
CHSSNDKKSQKFATE	MED17	346	Q9NVC6
HFFKLSQTSSKNLLN	PIK3R1	246	P27986
SFKSENFRHTKELNC	ITGA2	1036	P17301
SISFSKNAFKCTDHD	MTERF2	266	Q49AM1
SIKSLKFCHSQLSNN	ICOS	76	Q9Y6W8
KFCHSQLSNNSVSFF	ICOS	81	Q9Y6W8
INATNIKHFKNCTSI	EGFR	351	P00533
SKHCIKINSKNAESF	BRCA2	2546	P51587
SQKCSFYLADKNITH	ENPP3	676	O14638
ENFCKHNGSKNVFST	ATL3	426	Q6DD88
TCEIFHKQNSKLNSG	GEN1	496	Q17RS7
CLTDTNLFQKNSSFH	CEP57L1	426	Q8IYX8
KHSFDSASNKNFSQC	ESCO1	501	Q5FWF5
SASNKNFSQCLESKL	ESCO1	506	Q5FWF5
NSFEKQVSCHENSKS	SCAF11	116	Q99590
VFQQSSKQSLFDSCK	SLC15A4	286	Q8N697
QSKDAQYTVTFSHCK	KIF13A	916	Q9H1H9
SILHFDKNETQKTCQ	FREM3	1951	P0C091
FLHTNSKAFTAKTSC	SNX11	41	Q9Y5W9
TLFNTNLKDNKSSHF	SEPTIN14	71	Q6ZU15
AFSKSKSECTQLHLN	FILIP1	441	Q7Z7B0
CFRFFSTNSNLSKHK	PRDM15	831	P57071
CNQLKHKATQETSFD	NEPRO	316	Q6NW34
HKATQETSFDFKCSQ	NEPRO	321	Q6NW34
RQQAFCSQASKHTTK	SEC31B	521	Q9NQW1
KFQSFIESCLVKNHS	TNIK	261	Q9UKE5
ECCKAFNKFSNLTQH	ZNF678	241	Q5SXM1
ECGKAFNKFSSLTQH	ZNF678	381	Q5SXM1
LCSATTHSKNFQCNK	ZNF695	146	Q8IW36
VCGKAFTKSSQLFQH	ZNF383	286	Q8NA42
KCQKIFSFAHQTISA	VPS35	556	Q96QK1
QCFKVFSTKSNLTQH	ZNF558	156	Q96NG5
QCLSTTQNKIFQTHK	ZNF679	146	Q8IYX0
ECGKSFQKFSDLTQH	ZNF721	101	Q8TF20
TSECFQNFSQSHKCI	TMEM116	46	Q8NCL8
KCKFSTQDVGTFVQH	ZNF518A	211	Q6AHZ1
SKNSIFFVKSSDFQH	TLR7	501	Q9NYK1
CGKFFNQSTNLTTHK	ZNF730	261	Q6ZMV8
LSQKFHKFDSCENSL	ZNF630	171	Q2M218
CAKAFNQSSNLTEHK	ZNF43	291	P17038
ECGKAFNQFSTLTKH	ZNF43	626	P17038
CEKAFSQKSQLNTHQ	ZNF84	576	P51523
EKSFSQSSTLFQHQK	ZNF22	61	P17026
KHCDFNNKSARSVST	ZNF462	846	Q96JM2
KTFSQSSNFAKHQRI	ZNF286B	446	P0CG31
ECGKSFQKFSDLTQH	ZNF732	171	B4DXR9
TISFNKSAKQFSSHI	TRAV23DV6	91	A0A075B6W5
CTINAKENDFKHFHS	XRRA1	106	Q6P2D8
QCSSTTHSKIFQYNK	ZNF195	206	O14628
SSKLFQNCSELFKTQ	TMEM87A	121	Q8NBN3
THKRDFSEIKSQQCQ	TTF2	211	Q9UNY4
DNLFKCTDAVKSFNH	ZNF606	286	Q8WXB4